![](/img/cover-not-exists.png)
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial
Karn, Thomas, Meissner, Tobias, Weber, Karsten E., Solbach, Christine, Denkert, Carsten, Engels, Knut, Fasching, Peter A., Sinn, Bruno V., Schrader, Iris, Budczies, Jan, Marmé, Frederik, Müller, VolJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-19-1954
Date:
January, 2020
File:
PDF, 887 KB
2020